VERPELLI, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.253
NA - Nord America 1.138
EU - Europa 369
SA - Sud America 233
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 27
OC - Oceania 4
Totale 3.092
Nazione #
US - Stati Uniti d'America 1.094
SG - Singapore 549
CN - Cina 274
BR - Brasile 177
HK - Hong Kong 143
IT - Italia 117
VN - Vietnam 116
NL - Olanda 82
FR - Francia 61
KR - Corea 39
BD - Bangladesh 26
DE - Germania 24
JP - Giappone 22
AR - Argentina 21
CA - Canada 21
FI - Finlandia 21
IN - India 21
GB - Regno Unito 18
CO - Colombia 10
EC - Ecuador 9
MX - Messico 9
ID - Indonesia 8
IQ - Iraq 8
VE - Venezuela 8
ES - Italia 7
IL - Israele 7
SE - Svezia 7
TR - Turchia 7
JM - Giamaica 6
RU - Federazione Russa 6
TH - Thailandia 6
ZA - Sudafrica 6
KE - Kenya 5
MA - Marocco 5
IE - Irlanda 4
MY - Malesia 4
PY - Paraguay 4
SA - Arabia Saudita 4
LV - Lettonia 3
RO - Romania 3
UA - Ucraina 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
CD - Congo 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GN - Guinea 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.025
Città #
Santa Clara 322
Singapore 302
San Jose 220
Hong Kong 142
Hefei 96
Beijing 82
Ashburn 73
Lauterbourg 52
Ho Chi Minh City 38
Seoul 37
Los Angeles 33
Hanoi 31
Dallas 24
São Paulo 24
Milan 20
Buffalo 16
Rome 15
Tokyo 15
New York 11
Council Bluffs 10
Lappeenranta 9
Helsinki 8
Munich 8
Amsterdam 7
Dhaka 7
Montreal 7
Atlanta 6
Guangzhou 6
Haiphong 6
Houston 6
Jacksonville 6
Orem 6
Bengaluru 5
Brasília 5
Cagliari 5
Chicago 5
Minamishinagawa 5
Nairobi 5
Palermo 5
Sesto San Giovanni 5
Stockholm 5
Belo Horizonte 4
Charlotte 4
Curitiba 4
Denver 4
Dublin 4
Florence 4
Guayaquil 4
Marseille 4
Naples 4
Secaucus 4
Brooklyn 3
Buenos Aires 3
City of London 3
Frankfurt am Main 3
Goiânia 3
Johannesburg 3
Manchester 3
Mexico City 3
Norristown 3
Nuremberg 3
Porto Alegre 3
Queens 3
Riga 3
San Francisco 3
Seattle 3
Shanghai 3
Shijiazhuang 3
Tampa 3
Tashkent 3
The Bronx 3
Turku 3
Washington 3
Ankara 2
Araruama 2
Arlington 2
Asunción 2
Auckland 2
Baghdad 2
Bandung 2
Barzago 2
Baton Rouge 2
Biên Hòa 2
Blumenau 2
Bogotá 2
Bologna 2
Bucharest 2
Bình An 2
Cairo 2
Campos dos Goytacazes 2
Cape Town 2
Caracas 2
Chennai 2
Cleveland 2
Des Moines 2
Elizabeth 2
Florissant 2
Ha Long 2
Hamilton 2
Hoffman Estates 2
Totale 1.850
Nome #
High Aspect Ratio and Light-Sensitive Micropillars Based on a Semiconducting Polymer Optically Regulate Neuronal Growth 88
AIMTOR, a BRET biosensor for live imaging, reveals subcellular mTOR signaling and dysfunctions 84
Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles 84
Modelling genetic mosaicism of neurodevelopmental disorders in vivo by a Cre-amplifying fluorescent reporter 81
SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse 66
The X-linked intellectual disability protein IL1RAPL1 regulates dendrite complexity 66
Deletion of calcineurin from astrocytes reproduces proteome signature of Alzheimer's disease and epilepsy and predisposes to seizures 66
Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. 64
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer’s disease 64
Dimerizable redox-sensitive triazine-based cationic lipids for in vitro gene delivery 64
Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome 63
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice. 62
CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. 61
Shank2 identifies a subset of glycinergic neurons involved in altered nociception in an autism model 61
Rescuing Epileptic and Behavioral Alterations in a Dravet Syndrome Mouse Model by Inhibiting Eukaryotic Elongation Factor 2 Kinase (eEF2K) 60
Different attentional dysfunctions in eEF2K(-/-), IL1RAPL1(-/-) and SHANK3 Delta 11(-/-) mice 58
Restoring glutamate receptosome dynamics at synapses rescues autism-like deficits in Shank3-deficient mice 57
Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases 57
Shank3 deletion in PV neurons is associated with abnormal behaviors and neuronal functions that are rescued by increasing GABAergic signaling 56
Activation of the medial preoptic area (MPOA) ameliorates loss of maternal behavior in a Shank2 mouse model for autism 55
N-methyl-D-aspartate receptor function in neuronal and synaptic development and signaling 54
Micro/nanostructured conjugated polymer-based systems for the optical modulation of living cells activity 54
Shank synaptic scaffold proteins: Keys to understanding the pathogenesis of autism and other synaptic disorders 53
Shank2/3 double knockout-based screening of cortical subregions links the retrosplenial area to the loss of social memory in autism spectrum disorders 51
SULT4A1 modulates synaptic development and function by promoting the formation of PSD-95/NMDAR complex 49
High-Aspect-Ratio Semiconducting Polymer Pillars for 3D Cell Cultures 48
Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target 48
SOD1 stimulates lamellipodial protrusions in Neuro 2A cell lines 48
SHANK genes in autism: Defining therapeutic targets 48
The Up and Down of the N-Methyl-D-Aspartate Receptor That Causes Autism 47
Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons 47
The Synaptic and Neuronal Functions of the X-Linked Intellectual Disability Protein Interleukin-1 Receptor Accessory Protein Like 1 (IL1RAPL1) 47
Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis. 46
Transcriptional diversity in specific synaptic gene sets discriminates cortical neuronal identity 45
The postsynaptic density proteins Homer and Shank form a polymeric network structure. 44
Proteomic analysis of post-synaptic density fractions from Shank3 mutant mice reveals brain region specific changes relevant to autism spectrum disorder 42
eEF2K/eEF2 Pathway Controls the Excitation/Inhibition Balance and Susceptibility to Epileptic Seizures 42
Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice 42
The GluR2 subunit inhibits tumor proliferation by inactivating the src-erk1/2 cascade and induces apoptosis by means of caspase 376-dependent activation in glioma cells. 41
Anti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastoma. 41
SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region 40
Proteomic analysis of activity-dependent synaptic plasticity in hippocampal neurons. 40
Mutations of the synapse genes and intellectual disability syndromes 39
Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells 39
Modelling autistic neurons with induced pluripotent stem cells 39
Glial degeneration with oxidative damage drives neuronal demise in MPSII disease 36
Regulation of Dendrite and Dendritic Spine Formation by TCF20 36
Alternative splicing of the histone demethylase LSD1/KDM1 contributes to the modulation of neurite morphogenesis in the mammalian nervous system. 35
Scaffold proteins at the postsynaptic density 34
Homer1b/c clustering is impaired in Phelan-McDermid Syndrome iPSCs derived neurons 34
Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness 34
Molecular basis for prospective pharmacological treatment strategies in intellectual disability syndromes. 34
Phosphorylation of neuronal Lysine-Specific Demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2 34
Molecular and synaptic defects in intellectual disability syndromes 34
Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage. 33
Spikar speaks to spines and nuclei 33
Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency 32
Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD. 31
Shank3 modulates Rpl3 expression and protein synthesis via mGlu5: implications for Phelan McDermid syndrome 30
Expression of Cocaine-Evoked Synaptic Plasticity by GluN3A-Containing NMDA Receptors 29
Antiangiogenic therapy for glioma. 29
The neuropeptide PACAP38 induces dendritic spine remodeling through ADAM10-N-cadherin signaling pathway. 29
CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. 29
Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma. 28
ALS Mutations Shift the Isoelectric Point of the KIF5A C Terminal Inducing Protein Aggregation and TDP-43 Mislocalization 27
Totale 3.092
Categoria #
all - tutte 10.184
article - articoli 9.839
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 167
Totale 20.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.124 2 3 65 27 262 80 17 98 53 75 231 211
2025/20261.640 68 137 144 187 317 44 267 70 110 119 99 78
2026/2027328 83 67 178 0 0 0 0 0 0 0 0 0
Totale 3.092